Aviva Systems Biology
Private Company
Funding information not available
Overview
Aviva Systems Biology is a established, revenue-generating provider of essential research reagents for the global life science market. Its core business revolves around a large catalog of antibodies, ELISA kits, and recombinant proteins, supplemented by custom service offerings like its 'Protein on Demand™' platform. The company serves a wide range of research areas from cancer and neuroscience to immunology and infectious disease, positioning itself as a one-stop shop for academic, biotech, and pharmaceutical researchers. Its operational focus is on product breadth, validation, and custom solutions rather than therapeutic or diagnostic development.
Technology Platform
Integrated reagent development platform specializing in antibody generation (monoclonal, polyclonal, recombinant), recombinant protein expression (Protein on Demand™), and ELISA kit development and validation.
Opportunities
Risk Factors
Competitive Landscape
Aviva competes in the crowded life science reagents market against giants like Thermo Fisher, Abcam, and Bio-Techne, as well as numerous specialized antibody producers. It differentiates through its large catalog of validated ELISA kits, custom service flexibility, and focus on recombinant antibody technology.